ACKR3 and urinary bladder carcinoma: A recent study demonstrated that using a CXCR7 antagonist, CCX733 drastically reduced EMT in bladder cancer, which suggests the importance of CXCR7 in regulating EMT and in the development of bladder cancer [22].